Menzaghi Claudia

Claudia Menzaghi si occupa di eredità e genetica dell'insulino-resistenza e delle complicanze cardio- e nefro-vascolari del diabete di tipo 2. Coordina progetti di ricerca sul ruolo delle adipocitochine, come adiponectina e resistina, caratterizzandole come possibili predittori di malattia.

linkedin researchgate

Informazioni aggiuntive

  • Pubblicazioni Scientifiche:

    Totale pubblicazioni a partire dal 2011: 39


    Anno

    2019; (): e728

    Association of a homozygous GCK missense mutation with mild diabetes.

    Marucci A, Biagini T, Di Paola R, Menzaghi C, Fini G, Castellana S, Cardinale GM, Mazza T, Trischitta V


    2018; ():

    Circulating adiponectin levels are paradoxically associated with mortality rate. A systematic review and meta-analysis.

    Scarale MG, Fontana A, Trischitta V, Copetti M, Menzaghi C


    2018; ():

    Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

    Delvecchio M, Salzano G, Bonura C, Cauvin V, Cherubini V, d'Annunzio G, Franzese A, Giglio S, Grasso V, Graziani V, Iafusco D, Iughetti L, Lera R, Maffeis C, Maltoni G, Mantovani V, Menzaghi C, Patera PI, Rabbone I, Reindstadler P, Scelfo S, Tinto N, Toni


    2018; 67(1): 12-22

    The Adiponectin Paradox for All-Cause and Cardiovascular Mortality.

    Menzaghi C, Trischitta V


    2017; 60(S1): 513-514

    Combined effect of high sensitive C-reactive protein and serum amyloid component P on mortality rate in patients with type 2 diabetes

    Menzaghi C., Scarale M.G., Salvemini L., Copetti M., Trischitta V.

    2017; 66(S1): a434

    Combined Effect of High Sensitive C-Reactive Protein (hs-CRP) and Serum Amyloid Component P (SAP) on Mortality Rate in Type 2 Diabetes

    Menzaghi C., Scarale M.G., Salvemini L., Copetti M., Trischitta V.

    2017; 37(5): e55-e56

    Letter by Menzaghi et al Regarding Article, "Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study".

    Menzaghi C, Copetti M, Trischitta V


    2017; 7(): 44337

    Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals.

    Menzaghi C, Marucci A, Antonucci A, De Bonis C, Ortega Moreno L, Salvemini L, Copetti M, Trischitta V, Di Paola R


    2017; 7(1): 61

    Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data.

    Fontana A, Ortega Moreno L, Lamacchia O, De Bonis C, Salvemini L, De Cosmo S, Cignarelli M, Copetti M, Trischitta V, Menzaghi C


    2016; 59 (suppl 1): S512

    Role of the "resistin pathway" on cardiovascular risk factors and major cardiovascular events

    Menzaghi C., Marucci A., Antonucci A., De Bonis C., Ortega Moreno L., Salvemini L., Copetti M., Trischitta V., Di Paola R.

    2016; 59 (suppl1): S138-139

    The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: evidence of synergism with abdominal adiposity

    Ortega Moreno L., Lamacchia O., Fontana A., Copetti M., Salvemini L., De Bonis C., Cignarelli M., Trischitta V., Menzaghi C.

    2016; 250(): 23-29

    The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: Evidence of synergism with abdominal adiposity.

    Ortega Moreno L, Lamacchia O, Fontana A, Copetti M, Salvemini L, De Bonis C, Cignarelli M, Trischitta V, Menzaghi C


    2016; 15(1): 17

    Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes.

    Ortega Moreno L, Copetti M, Fontana A, De Bonis C, Salvemini L, Trischitta V, Menzaghi C


    2016; 245(): 222-227

    The paradoxical association of adiponectin with mortality rate in patients with type 2 diabetes: evidence of synergism with kidney function.

    Ortega Moreno L, Lamacchia O, Salvemini L, De Bonis C, De Cosmo S, Cignarelli M, Trischitta V, Menzaghi C


    2015; 10(10): e0140631

    Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes.

    Ortega Moreno L, Lamacchia O, Copetti M, Salvemini L, De Bonis C, De Cosmo S, Cignarelli M, Trischitta V, Menzaghi C


    2015; 58 (Suppl 1): S542

    Serum adiponectin and glomerular filtration rate in patients with type 2 diabetes

    Ortega Moreno L., Lamacchia O., Salvemini L., De Cosmo S., Cignarelli M., Trischitta V., Menzaghi C.

    2015; ():

    Strong evidence of sexual dimorphic effect of adiposity excess on insulin sensitivity.

    Marucci A, Menzaghi C, Copetti M, Vinciguerra F, Baratta R, Salvemini L, Morini E, Frittitta L, Di Paola R, Trischitta V


    2015; 10(3): e0120419

    Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis.

    Fontana A, Spadaro S, Copetti M, Spoto B, Salvemini L, Pizzini P, Frittitta L, Mallamaci F, Pellegrini F, Trischitta V, Menzaghi C


    2015; 10(3): e0119529

    Serum resistin and glomerular filtration rate in patients with type 2 diabetes.

    Ortega Moreno L, Salvemini L, Mendonca C, Copetti M, De Bonis C, De Cosmo S, Doria A, Trischitta V, Menzaghi C


    2014; 57: S149

    Insulin signalling genes exert a combined effect on all-cause mortality

    Menzaghi C., Fontana A., Copetti M., Rizza S., Spoto B., Tripepi G., Marucci A., Testa A., Mallamaci F., De Cosmo S., Bacci S., Federici M., Zoccali C., Trischitta V.

    2014; 63: A417

    Insulin Signaling Genes Exert a Combined Effect on All-Cause

    Menzaghi C., Bacci S., Fontana A., Rizza S., Spoto B., Tripepi G., Marucci A., Testa A., Copetti M., Mallamaci F., De Cosmo S., Federici M., Zoccali C., Trischitta V.

    2014; 63: A349

    Circulating Resistin Levels and Mortality Risk

    Fontana A., Spadaro S., Marucci A., Salvemini L., Copetti M., Frittitta L., Bacci S., Pellegrini F., Trischitta V., Menzaghi C.

    2014; 37(12): e258-60

    Low Prevalence of HNF1A Mutations After Molecular Screening of Multiple MODY Genes in 58 Italian Families Recruited in the Pediatric or Adult Diabetes Clinic From a Single Italian Hospital.

    Delvecchio M, Ludovico O, Menzaghi C, Di Paola R, Zelante L, Marucci A, Grasso V, Trischitta V, Carella M, Barbetti F


    2014; 40(): 58

    Clinical heterogeneity of abnormal glucose homeostasis associated with the HNF4A R311H mutation.

    Delvecchio M, Di Paola R, Mangiacotti D, Sacco M, Menzaghi C, Trischitta V


    2014; : 639-644

    Joint effect of insulin signaling genes on all-cause mortality

    Menzaghi c., fontana A., Copetti M., rizza S., Spoto B., Buranasupkajorn P., Tripepi G., marucci A., Bailetti D., Hastings T., Testa A., Mendoca C., Mallamaci F., De Cosmo S., Bacci S., Federici M., Doria A., Zoccali C., Trischitta V.

    2014; 13(1): 130

    Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism.

    Menzaghi C, Xu M, Salvemini L, De Bonis C, Palladino G, Huang T, Copetti M, Zheng Y, Li Y, Fini G, Hu FB, Bacci S, Qi L, Trischitta V


    2013; 36(9): 2830-5

    Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes.

    De Cosmo S, Copetti M, Lamacchia O, Fontana A, Massa M, Morini E, Pacilli A, Fariello S, Palena A, Rauseo A, Viti R, Di Paola R, Menzaghi C, Cignarelli M, Pellegrini F, Trischitta V


    2013; 56: S536

    Evidence for sex-specific effect of serum total adiponectin on cardiovascular death in patients with type 2 diabetes mellitus

    Menzaghi C., Xu M., Salvemini L., De Bonis C., Fini G., Palladino G., Bacci S., Qi L., Trischitta V.

    2013; 5: S172

    Evidence of reverse epidemiology between obesity and all-cause mortality in whites with type 2 diabetes from Italy

    Di Paola R., Marucci A., Fontana A., Menzaghi C., Salvemini L., Copetti M., Pellegrini F., De Cosmo S., Trischitta V.

    2013; ():

    Role of obesity on all-cause mortality in whites with type 2 diabetes from Italy.

    Di Paola R, Marucci A, Fontana A, Menzaghi C, Salvemini L, Copetti M, Pellegrini F, De Cosmo S, Trischitta V


    2013; 8(7): e70159

    GALNT2 Expression Is Reduced in Patients with Type 2 Diabetes: Possible Role of Hyperglycemia.

    Marucci A, di Mauro L, Menzaghi C, Prudente S, Mangiacotti D, Fini G, Lotti G, Trischitta V, Di Paola R


    2013; 8(6): e64729

    Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.

    Menzaghi C, Bacci S, Salvemini L, Mendonca C, Palladino G, Fontana A, De Bonis C, Marucci A, Goheen E, Prudente S, Morini E, Rizza S, Kanagaki A, Fini G, Mangiacotti D, Federici M, De Cosmo S, Pellegrini F, Doria A, Trischitta V


    2013; :

    Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes mellitus

    De Cosmo S, Copetti M, Lamacchia O, Fontana A, Michela M, Morini E, Pacilli A, Fariello S, Palena A, Rauseo A, Viti R, Di Paola R, Menzaghi C, Cignarelli M, Pellegrini F, Trischitta V,

    2012; 21(21): 4774-80

    Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels.

    Qi Q, Menzaghi C, Smith S, Liang L, de Rekeneire N, Garcia ME, Lohman KK, Miljkovic I, Strotmeyer ES, Cummings SR, Kanaya AM, Tylavsky FA, Satterfield S, Ding J, Rimm EB, Trischitta V, Hu FB, Liu Y, Qi L


    2012; ():

    Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.

    De Cosmo S, Menzaghi C, Prudente S, Trischitta V


    2012; 7(6): e38414

    Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals.

    Menzaghi C, Salvemini L, Fini G, Thompson R, Mangiacotti D, Di Paola R, Morini E, Giorelli M, De Bonis C, De Cosmo S, Doria A, Trischitta V


    2011; 60(8): 2197-201

    Novel locus FER is associated with serum HMW adiponectin levels.

    Qi L, Menzaghi C, Salvemini L, De Bonis C, Trischitta V, Hu FB


    2011; ():

    The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.

    Prudente S, Morini E, Larmon J, Andreozzi F, Di Pietro N, Nigro A, Gervino EV, Mannino GC, Bacci S, Hauser TH, Bellacchio E, Formoso G, Pellegrini F, Proto V, Menzaghi C, Frittitta L, Pandolfi A, Sesti G, Doria A, Trischitta V


    2011; 54(4): 812-8

    Relationship between ADIPOQ gene, circulating high molecular weight adiponectin and albuminuria in individuals with normal kidney function: evidence from a family-based study.

    Menzaghi C, De Cosmo S, Copetti M, Salvemini L, De Bonis C, Mangiacotti D, Fini G, Pellegrini F, Trischitta V


    {accordionfaq faqid=accordion3 faqclass="lightnessfaq defaulticon headerbackground headerborder contentbackground contentborder round5" active=0}

nuovo-css

webcamlive

Newsletter

Informativa Newsletter
  twitter   facebook   youtube